Autoimmunity Reviews

Article	Citations
Novel aspects of muscle involvement in immune-mediated inflammatory arthropathies and connective tissue diseases	401
The rationale for the use of corticosteroids in early severe Guillain-Barré syndrome	295
Prevalence of immune-mediated inner ear disease in non-segmental vitiligo: A cross-sectional study	226
Editorial Board	171
Editorial Board	145
Cardiovascular disease risk in systemic lupus erythematous: Certainties and controversies	129
Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: A systematic review and meta-analysis	129
Systemic lupus erythematosus and male reproductive health: A systematic review and meta-analysis	97
Diagnostic approach in giant cell arteritis	88
Disease-modifying strategies: Targeting protein kinases in multiple sclerosis and other autoimmune disorders	88
Maternal and fetal outcomes in Latin American SLE pregnancies: A systematic review and meta-analysis	85
Human mesenchymal stem cells for the management of systemic sclerosis. Systematic review	83
Current state of epigenetics in giant cell arteritis: Focus on microRNA dysregulation	81
Editorial Board	78
Rituximab-induced cystoid macular edema in a patient with systemic lupus erythematosus: A case report and literature review	72
Inflammatory muscle involvement in systemic vasculitis: A systematic review	69
Lymphocyte activation gene-3 (LAG-3) regulatory T cells: An evolving biomarker for treatment response in autoimmune diseases	68
Current landscape of monogenic autoinflammatory actinopathies: A literature review	66
Anti-HMGCR immune-mediated necrotising myopathy: Addressing the remaining issues	66
Characteristics and risk factors for infection in patients with ANCA-associated vasculitis: A systematic review and meta-analysis	63
“Fibromyalgia syndrome” related to Essure devices	59
Genetic and genomic associations in antiphospholipid syndrome: A systematic review	59
Isoprostanes in systemic lupus erythematosus and antiphospholipid syndrome: A systematic review and meta-analysis	58
Type I Interferon as cardiovascular risk factor in systemic and cutaneous lupus erythematosus: A systematic review	56
Antiphospholipid antibodies and COVID-19	56

Diagnostic yield of combined cranial and large vessel PET/CT, ultrasound and MRI in giant cell arteritis: A systematic review and meta-analysis	55
Susac syndrome: A scoping review	54
Immune-mediated necrotizing myopathy (IMNM): A myopathological challenge	54
A strategy towards disentangling treatment refractory from misdiagnosed axial Spondyloarthritis	53
Differentially expressed genes in systemic sclerosis: Towards predictive medicine with new molecular tools for clinicians	53
Role of regulatory T cells in inflammatory liver diseases	52
Persistent aortic inflammation in patients with giant cell arteritis	52
Editorial Board	50
Is minor salivary gland biopsy still mandatory in Sjogren's syndrome? Does seronegative Sjogren's syndrome exist?	48
TAFRO syndrome: A severe manifestation of Sjogren's syndrome? A systematic review	48
Editorial Board	48
Leflunomide: A safe and effective alternative in systemic lupus erythematosus	46
Rapidly progressive interstitial lung disease in clinically amyopathic dermatomyositis triggered by a 23-valent pneumococcal polysaccharide vaccine	44
Editorial Board	43
From inflammation to renal fibrosis: A one-way road in autoimmunity?	43
Boolean analysis of the transcriptomic data to identify novel biomarkers of IVIG response	43
Potential immunological and genetic markers associated with lupus nephritis: From pathogenicity to therapeutic drug target	41
Emerging role of galectin family in inflammatory autoimmune diseases	40
Aquaporins: Unexpected actors in autoimmune diseases	40
Efferocytosis: Unveiling its potential in autoimmune disease and treatment strategies	40
Molecular mimicry between SARS-CoV-2 and human proteins	39
Persistence of antiphospholipid antibodies over time and its association with recurrence of clinical manifestations: A longitudinal study from a single centre	39
Immune and non-immune mechanisms that determine vasculitis and coronary artery aneurysm topography in Kawasaki disease and MIS-C	39
Histopathological prognostic factors in ANCA-associated glomerulonephritis.	39
Key points to consider for an improved detection and characterization of cryoglobulins	39
When should targeted therapies be used in the treatment of lupus nephritis: Early in the disease course or in refractory patients?	38
Editorial Board	38
Proteomics and enriched biological processes in Antiphospholipid syndrome: A systematic review	37
Pulmonary arterial hypertension associated with connective tissue diseases (CTD-PAH): Recent and advanced data	35
Increased risk of acute and chronic microvascular renal lesions associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review and meta-analysis	35
Caffeine and rheumatoid arthritis: A complicated relationship	34
Successful treatment of IgG4-related disease with tocilizumab monotherapy	34
Interaction between endothelial cell-derived extracellular vesicles and monocytes: A potential link between vascular thrombosis and pregnancy-related morbidity in antiphospholipid syndrome	34
Janus-kinase inhibitor use in immune-mediated inflammatory diseases beyond licensed indications: A scoping review	34
Risk relationship between six autoimmune diseases and malignancies: An umbrella review	33
Unraveling the global burden of inflammatory bowel disease (1990–2019): A Joinpoint regression analysis of divergent trends in 10–24 and 50–69 age cohorts	33
Framework for implementing treat-to-target in systemic lupus erythematosus routine clinical care: consensus statements from an international task force	33
Ocular involvement in monogenic autoinflammatory disease	32
Antinuclear antibodies in individuals with COVID-19 reflect underlying disease: Identification of new autoantibodies in systemic sclerosis (CDK9) and malignancy (RNF20, RCC1, TRIP13)	32
Ocular microvascular damage in autoimmune rheumatic diseases: The pathophysiological role of the immune system	32
Subcutaneous tissue involvement in idiopathic inflammatory myopathies: Systematic literature review including three new cases and hypothetical mechanisms	32
Salivary gland involvement in ANCA-associated vasculitis	31
The mechanism behind flaring/triggering of autoimmunity disorders associated with COVID-19	30
Burden of inflammatory bowel disease among elderly, 1990–2019: A systematic analysis based on the global burden of disease study 2019	30
Risk factors associated with thrombocytopenia in systemic lupus erythematosus: A systematic review and meta-analysis	30
Is it time for treat-to-target in antiphospholipid syndrome?	30
T lymphocyte plasticity in chronic inflammatory diseases: The emerging role of the Ikaros family as a key Th17-Treg switch	30
The role of innate immunity in myasthenia gravis	29
Epidemiology of major relapse in giant cell arteritis: A study-level meta-analysis	29
B lymphocytes, the gastrointestinal tract and autoimmunity	29

Pemphigoid of the pulmonary system (POPS): A review of a less recognized feature	28
Serum calprotectin is a marker of disease activity in Giant cell arteritis	28
Prevention of rheumatoid arthritis: A systematic literature review of preventive strategies in at-risk individuals	28
Low-dose interleukin-2: A potential treatment for pemphigus vulgaris	26
Tyrosine kinase 2 inhibitors in autoimmune diseases	26
Development of systemic lupus erythematosus in patients with immune thrombocytopenic purpura: A systematic meta-analysis	26
Comprehensive reproductive healthcare for women with immune-mediated inflammatory diseases: Addressing rheumatoid arthritis, spondyloarthritis and inflammatory bowel disease through life's stages	26
Characteristics and prognosis of IgG4-related skin disease: A case report and systematic literature review	26
Autoreactive T cells of ankylosing spondylitis elicited by COVID-19 infection: A snapshot of immunological host defense and autoimmune imprinting	26
Vitamin D deficiency and non-infectious uveitis: A systematic review and Meta-analysis	26
Gut-tropic T cells and extra-intestinal autoimmune diseases	26
Endometriosis and autoimmunity	25
IgA vasculitis in adult patient following vaccination by ChadOx1 nCoV-19	25
Nutrition and its role in prevention and management of rheumatoid arthritis	25
The revisited role of interleukin-1 alpha and beta in autoimmune and inflammatory disorders and in comorbidities	25
Intravenous immunoglobulins reduce skin thickness in systemic sclerosis: evidence from Systematic Literature Review and from real life experience	24
A critical view on autoantibodies in lupus nephritis: Concrete knowledge based on evidence	24
Treatment of acute exacerbation in interstitial lung disease secondary to autoimmune rheumatic diseases: More questions than answers	24
Should we use nintedanib as early therapy in patients with SSc-ILD?	24
Issues in autoantibody tests used in the classification criteria for autoimmune rheumatic diseases: the laboratory autoimmunologist's perspective	24
The biology of symptom-based disorders – time to act	23
Osteonecrosis in systemic lupus erythematosus: Systematic insight from the epidemiology, pathogenesis, diagnosis and management	23
Immunometabolic shifts in autoimmune disease: Mechanisms and pathophysiological implications	23
The seasonality of Dermatomyositis associated with anti-MDA5 antibody: An argument for a respiratory viral trigger	23
Macrophages in Lupus Nephritis: Exploring a potential new therapeutic avenue	23
Is it safe to withdraw low-dose glucocorticoids in SLE patients in remission?	23
Transverse myelitis in systemic lupus erythematosus: A case report and systematic literature review	22
Emerging role of the cGAS-STING signaling pathway in autoimmune diseases: Biologic function, mechanisms and clinical prospection	22
JAK inhibitors and psoriatic arthritis: A systematic review and meta-analysis	22
Renal involvement in systemic sclerosis	22
Circulating and skin biopsy-present cytokines related to the pathogenesis of cutaneous lupus erythematosus	21
Significance of IL-7 and IL-7R in RA and autoimmunity	21
Circulating Calprotectin (cCLP) in autoimmune diseases	21
Global burden and cross-country inequalities in autoimmune diseases from 1990 to 2019	21
JAK inhibitors and systemic sclerosis: A systematic review of the literature	21
The role of musculoskeletal ultrasound in difficult-to-treat RA: Insights from a systematic literature review	21
Arterial stiffness, the hidden face of cardiovascular risk in autoimmune and chronic inflammatory rheumatic diseases	21
Treatment of autoimmunity: The impact of disease-modifying therapies in multiple sclerosis and comorbid autoimmune disorders	20
Antiphospholipid syndrome in the era of COVID-19 – Two sides of a coin	20
Pharmacological treatments for SSc-ILD: Systematic review and critical appraisal of the evidence	20
Editorial Board	20
Non-pharmacological interventions in the treatment of rheumatoid arthritis: A systematic review and meta-analysis	20
Psychiatric manifestations of autoimmune encephalitis	20
Recommendations for randomised controlled trials on fibromyalgia and myalgic encephalomyelitis	20
A comprehensive review of the advances in neuromyelitis optica spectrum disorder	20
Anti-alpha enolase multi-antibody specificity in human diseases. Clinical significance and molecular mechanisms	20
Immune mediated events timely associated with COVID-19 vaccine. A comment on article by Badier, et al.: “IgA vasculitis in adult patients following vaccination by ChadOx1 nCoV-19”	20
Editorial Board	20
Autoimmune pancreatitis - What we know and what do we have to know?	19
Cranial giant cell arteritis mimickers: A masquerade to unveil	19
Inflammatory bowel disease in primary immunodeficiency disorders is a heterogeneous clinical entity requiring an individualized treatment strategy: A systematic review	19
Editorial Board	19
Deciphering the clinical significance of longitudinal antiphospholipid antibody titers	19
To be, or not to be… Guillain-Barré Syndrome	19
Editorial Board	18
A call for uniformity in reporting patient level details during description of ophthalmologic major relapse among giant cell arteritis studies. A comment on article by Aussedat M et al. “Epidemiology	18
Comment on “Systemic lupus erythematosus and male reproductive health: A systematic review and meta-analysis”	18
Non-invasive imaging in antiphospholipid syndrome to assess subclinical coronary artery disease	18
The intervention of macrophages in progressive fibrosis characterizing systemic sclerosis: A systematic review	17
Infectious side effects of baricitinib: A big data analysis based on VigiBase	17
Research advances on targeted-Treg therapies on immune-mediated kidney diseases	17
Tumour- associated autoantibodies as prognostic cancer biomarkers- a review	17
Clinical impact and prognosis of cryoglobulinemia and cryofibrinogenemia in systemic sclerosis	17
The role of memory T cells in type 1 diabetes: Phenotypes, mechanisms, and therapeutic implications	16
Fecal microbiota transplantation in autoimmune diseases – An extensive paper on a pathogenetic therapy	16
MicroRNAs in pemphigus and pemphigoid diseases	16
Editorial Board	16
Advances in RNA therapy for the treatment of autoimmune diseases	16
COVID-19-related autoimmune disorders of central nervous system (CRAD-C): Is it a new entity?	16
Sjögren syndrome overlapping with ANCA-associated vasculitis: Four additional cases and systematic literature review	16
Cerebral iron accumulation in multiple sclerosis: Pathophysiology and therapeutic implications	16
Safety and immunological proof-of-concept following treatment with tolerance-inducing cell products in patients with autoimmune diseases or receiving organ transplantation: A systematic review and met	16
Heart rate variability (HRV): Checklist for observational and experimental studies	15
Risks and outcomes of pregnancy in neuromyelitis optica spectrum disorder: A comprehensive review	15
Inhibitors of Bruton's tyrosine kinase as emerging therapeutic strategy in autoimmune diseases	15
Intima media thickness of the carotid artery in primary antiphospholipid syndrome: A systematic review and meta-analysis	15
Human abdominal aortic aneurysm (AAA): Evidence for an autoimmune antigen-driven disease.	15
Physical exercise therapy for autoimmune neuroinflammation: Application of knowledge from animal models to patient care	15
Structural cell heterogeneity underlies the differential contribution of IL-17A, IL-17F and IL-23 to joint versus skin chronic inflammation	15
Homocysteine as a trigger and potential therapeutic target for autoimmune diseases	15

Don't mix apples and oranges. Reply to Azoulay et al.	15
The impact of menopause on multiple sclerosis	15
FcRn inhibitors: Transformative advances and significant impacts on IgG-mediated autoimmune diseases	15
Serum biomarkers and their relationship to axial spondyloarthritis associated with inflammatory bowel diseases	15
Editorial Board	14
Editorial Board	14
Drug-induced antiphospholipid syndrome: Analysis of the WHO international database	14
Identifying subsets of patients with undifferentiated connective tissue disease: Results from a prospective, real-world experience using particle-based multi-analyte technology	14
Combination of monoclonal antibodies targeting type 2 inflammation for severe asthma and eosinophilic granulomatosis with polyangiitis	14
ASIA (Shoenfeld's syndrome) due to hysteroscopic Essure sterilization	14
Blood-dominant disease in late-and-early-onset lupus: A systematic review and meta-analysis	14
Editorial Board	14
Editorial Board	14
Editorial Board	14
Basophils in autoimmunity: Systemic lupus erythematosus and more?	14